All In MedTech

FDA Clearance Tracker · K213913

leva Pelvic Health System

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jun 30, 2022 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Jun 30, 2022

Substantially Equivalent

Time to decision

197 days

Received Dec 15, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K213913
Device name
leva Pelvic Health System
Applicant
Renovia, Inc.
Applicant location
Boston, MA
Received
Dec 15, 2021
Decided
Jun 30, 2022
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 884.1425

Every decision under product code HIR

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code HIR. The earliest in FDA's data is K782083, decided Jan 3, 1979.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Renovia, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.